Join the In Vivo Engineering of Therapeutic Cells Summit to be brought up to speed on the revolutionary advances in payload delivery in cell and gene therapy.
In vivo gene engineering is fast becoming known as the future of cell and gene therapy with incredible amounts of investment seen in 2021, including the recent Moderna and Metagenomi collaboration alongside the partnership between Abintus Bio and MSKCC, and Tidal acquisition by Sanofi.